Skip to main content
. Author manuscript; available in PMC: 2015 Dec 1.
Published in final edited form as: Ann Surg Oncol. 2014 Jun 17;21(13):4133–4138. doi: 10.1245/s10434-014-3852-x

Table 4. Multivariate Analysis.

Variable level OR p-value 95% CI
Age <50 vs ≥50 years 23.08 0.001 3.713, 143.486
Breast MRI Yes vs No 1.27 0.732 0.328, 4.893
MRI follow-up recommended Yes vs No 6.79 0.043 1.058, 43.63
Reconstruction performed Yes vs No 5.25 0.018 1.329, 20.728
Obese (BM ≥ 30) Yes vs No 2.93 0.131 0.726, 11.818
Nodal Status Pos vs Neg 1.53 0.527 0.41, 5.711
History of benign biopsies Yes vs No 1.02 0.981 0.204, 5.087
Family history Yes vs No 2.6 0.225 0.555, 12.217
HR positive Yes vs No 2.61 0.515 0.146, 46.602
HER2 positive Yes vs No 21.82 0.011 2.026, 234.864
TNBC Yes vs No 10.32 0.17 0.369, 288.371
BRCA testing done Yes vs No 1.16 0.846 0.254, 5.308
BRCA mutation Yes vs No 18.15 0.062 0.86, 383.077
Youngest child < 6 years old Yes vs No 0.16 0.096 0.018, 1.388

Abbreviations: OR, odds ratio; CI, confidence interval; MRI, Magnetic resonance imaging; BMI, body mass index; HR, hormone receptor; HER2, human epidermal growth factor receptor 2; TNBC, triple negative breast cancer;